Results 121 to 130 of about 19,522,173 (311)

Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level

open access: yesAging and Cancer, EarlyView.
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley   +1 more source

Investigation of the molecular mechanisms underlying the invasive phenotype in a panel of lung cancer cell lines [PDF]

open access: yes, 2009
The research described in this thesis aimed to increase our knowledge of the molecular mechanisms by which lung cancer cells acquire the capacity to invade.
Muniyappa, Mohan Kumar
core   +2 more sources

Clinical and Computed Tomography Characteristics for Early Diagnosis of Peripheral Small-cell Lung Cancer

open access: yesCancer Management and Research, 2022
Xiaochuan Zhang,1,2,* Fajin Lv,1,* Binjie Fu,1 Wangjia Li,1 Ruiyu Lin,1 Zhigang Chu1 1Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People’s Republic of China; 2Department of Radiology,
Zhang X, Lv F, Fu B, Li W, Lin R, Chu Z
doaj  

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

open access: yesArthritis Care &Research, EarlyView.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci   +25 more
wiley   +1 more source

Gemcitabine Plus Conventional-Dose Epirubicin Versus Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Stage Iiib/Iv Non-Small Cell Lung Carcinoma-a Randomized Phase Ii Trial

open access: yes, 2011
BACKGROUND: Epirubicin was effective for the treatment of non-small cell lung carcinoma (NSCLC). This study compared the efficacy and safety of gemcitabine plus conventional- dose epirubicin (GE) with gemcitabine- cisplatin (GC) as first-line ...
許駿;郭頌鑫;胡賦强;鄭安理;施金元;余忠仁;林家齊;楊泮池;楊志新   +1 more
core  

An Unusual Primary Paraneoplastic Manifestation of Adenocarcinoma of Lung

open access: yesIndian Journal of Clinical Cardiology
Carcinoma of lung (CoL) is the fourth most common cancer in India. It is classified as either small-cell or non-small-cell lung cancer, with adenocarcinoma being the most common variant.
Kartik Pandurang Jadhav   +3 more
doaj   +1 more source

Non Small Cell Lung Carcinoma

open access: yesJurnal Radiologi Indonesia, 2017
Lina Choridah   +2 more
openaire   +2 more sources

Neuroendocrine differentiation in non-small cell lung carcinomas.

open access: yesIn vivo (Athens, Greece), 2000
The immunohistochemical expression of ten neuroendocrine and neural differentiation-related antigens in 200 specimens from patients with surgically resected non-small cell lung carcinomas were evaluated. Poorly differentiated adenocarcinomas and undifferentiated large cell carcinomas showed the highest percentage of positive samples (30%-60%) for the ...
BALDI, Alfonso   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy